Quality of Life and Health Status Among Prostate Cancer Survivors and Noncancer Population Controls
Authors
Affiliations
Objective: To examine whether quality of life (QOL), health status, and the relationships between them varied by having a prostate cancer history. This study helps to inform the interface between aging-related health decline and the survival state among older men with prostate cancer, which is an important yet understudied public health issue.
Methods: Hierarchical linear models were used to analyze the cross-sectional data from the nationally representative population-based Medical Expenditure Panel Survey. Using propensity score matching, survivors (respondents with prostate cancer history) and controls (respondents without a history of any cancer) (N = 193 pairs) were matched based on 7 sociodemographic and health-related factors. QOL was measured using the mental and physical component scores of the SF-12 (SF-36.org). Health status included comorbidities, activities of daily living (ADL), instrumental ADL, and depressed mood.
Results: In bivariate analyses, survivors reported worse physical (42.72 vs 45.45 respectively; P = .0040) and mental QOL (51.59 vs 53.73 respectively; P = .0295) and more comorbidities (3.25 vs 2.78 respectively; P = .0139) than controls. In multivariate analyses, for both survivors and controls, better physical QOL was associated with fewer comorbidities (P <.0001), no need help with ADL (P = .0011) and IADL (P = .0162), and less depressed mood (P <.0001); better mental QOL was associated with no need help with IADL (P = .0005) and less depressed mood (P <.0001).
Conclusion: QOL of older men is affected by physical, functional, and psychological factors rather than prostate cancer history. Clinicians need to attend to aging-related health issues when providing care for prostate cancer survivors to improve QOL.
Sletten R, Slaaen M, Oldervoll L, Skjellegrind H, Saltyte Benth J, Astrom L J Cancer Surviv. 2024; .
PMID: 39289307 DOI: 10.1007/s11764-024-01670-8.
Multimorbidity in people living with and beyond cancer: a scoping review.
Ahmad T, Gopal D, Chelala C, Dayem Ullah A, Taylor S Am J Cancer Res. 2023; 13(9):4346-4365.
PMID: 37818046 PMC: 10560952.
Tagai E, Hudson S, Diefenbach M, Xu J, Bator A, Marziliano A J Cancer Surviv. 2020; 15(1):110-118.
PMID: 32681305 PMC: 7872345. DOI: 10.1007/s11764-020-00916-5.
Reading S, Porter K, Slezak J, Harrison T, Gelfond J, Chien G Sex Med. 2017; 5(4):e219-e228.
PMID: 28827045 PMC: 5693455. DOI: 10.1016/j.esxm.2017.07.002.
Chambers S, Ng S, Baade P, Aitken J, Hyde M, Wittert G Psychooncology. 2016; 26(10):1576-1585.
PMID: 27943512 PMC: 5655930. DOI: 10.1002/pon.4342.